Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2023.337 | Development and Validation of Risk Scores Using Machine Learning Algorithms to Determine Empirical Antibiotics Therapy for Community-acquired Pneumonia | Dr. LUI Grace Chung Yan |
| 2024.161 | HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial |
Dr. LUI Grace Chung Yan 雷頌恩 |
| 2024.695 | Retrospective Observational Study on the Effectiveness of Different Antiviral Therapy regimens for Patients with HIV |
Dr. LUI Grace Chung Yan 雷頌恩 |
| 2024.139 | Implementation of Differentiated Service Delivery Model of Care for People Living with HIV with Comorbidities | Dr. LUI Grace Chung Yan |
| 2021.134 | An open-label randomized controlled trial on convalescent plasma for treatment of severe COVID-19 infection |
Dr. LUI Grace C.Y. 雷頌恩 |
| 2021.188 | Large-scale Population Screening of Pooled Viral Nucleic Acid Samples Using Concurrent Isothermal Amplification and Electrochemical Detection for Novel Infectious Diseases on a Disposable Chip |
Dr. LUI Grace C.Y. 雷頌恩 |
| 2023.503 | A cluster-randomized controlled pragmatic trial to evaluate antimicrobial stewardship strategies for short-course and oral-switch antibiotic therapy for bloodstream infections due to Enterobacterales | Dr. LUI Grace C.Y. |
| 2021.442 | Developing A Novel Liquid Biopsy-based Molecular Assay For The Diagnosis Of Tuberculosis |
Prof. LUI Grace C.Y. 雷頌恩 |
| 2020.228 | Bacterial infections and the role of biomarker in antibiotic stewardship among patients with COVID-19 |
Dr. LUI Grace C.Y. 雷頌恩 |
| 2024.332 | Validation of an inclusive and cost-effective high-performance clinical prediction model for Coronary artery disease in people living with HIV: A protocol for a secondary analysis of a case-control study | Dr. LUI Grace C.Y. |
| 2021.310 | Exercise and dietary counselling programme for people living with HIV with sarcopenia: A randomized controlled trial |
Dr. LUI Grace C. Y. 雷頌恩 |
| 2025.144 | A prospective study to evaluate the efficacy of glucagon-like peptide-1 agonist in the prevention and management of metabolic dysfunction-associated steatotic liver disease in obese type 2 diabetes mellitus patients | Dr. LUI Edmond Yat Man |
| 2022.326 | Automatic retinal image analysis (ARIA) for risk stratification of coronary artery disease risk in people living with HIV |
Prof LUI CHUNG YAN Grace 雷頌恩 |
| 2020.467 | A retrospective territory-wide cohort study to determine the incidence of bacterial infections, antibiotics consumption, and the role of procalcitonin in antibiotic stewardship among patients with COVID-19 |
Prof. LUI Chung Yan 雷頌恩 |
| 2020.336 | Prospective Study on Sessile Serrated Adenoma/Polyps in the Colorectum | Dr. LUI Abdul Rashid N.S. |
| 2022.431 | A Phase II/III, Double-Blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients with Moderate to Severe COVID-19 |
Dr. LUI Grace Chung Yan 雷頌恩 |
| 2009.466 | Prospective and controlled study on medial arch suppport in long distance running, comparing flat insole and tailor made medial arch support insole, by plantar pressure distribution and lower limb electromyogram | Mr LUE BO KONG |
| 2016.381 | Comparison of the Role of Whey Protein and Alpha-lactalbumin in Recovery of Muscle Damage, Muscle Soreness and Affective Responses after Strenuous Prolonged Endurance Exercise |
Ms. LU Qin 覃璐 |
| 2016.583 | Comparison of the pre-exercise ingestion effect between whey PRO and alpha-lactalbumin on substrate metabolism, muscle damage, affective responses and subsequence exercise performance |
Ms. LU Qin 覃璐 |
| 2014.388 | Observational study on risk factors of recurrence after breast-conserving surgery for Chinese early-stage breast cancer patients | Miss LU Qianyun |
| 2015.625 | Objective ways to assess the fetal facial profile features using 2D and 3D ultrasound |
Ms. LU Jing 路晶 |
| 2017.644 | Pitfalls in assessing chorioamnionicity: novel observations and literature review |
Ms. LU Jing 路晶 |
| 2014.048 | Would attention network function differentiate between healthy aging and mild neurocognitive disorder due to Alzheimer's disease (MND-AD)? | Ms Lu Hanna |
| 2025.118 | Personalized assessment of high-definition slow-oscillatory transcranial direct current stimulation (so-tDCS) in older adults with subjective cognitive and sleep complaints | Dr. LU Hanna |
| 2024.652 | Focused low-intensity hippocampal transcranial ultrasound stimulation (TUS) for modulating the glymphatic function and cognition in mild neurocognitive disorder due to Alzheimer’s disease: a randomized clinical trial | Dr. LU Hanna |
| 2021.658 | Development of a personalized turn-key solution to evaluate the treatment outcomes and adverse effects of slow-oscillatory transcranial direct current stimulation (so-tDCS) in elderly with subjective cognitive complaints | Dr. LU Hanna |
| 2023.171 | Simulation-informed modelling and personalized evaluation (SIMPLE): An MRI-based brain age matrices for predicting cognitive maintenance and healthy longevity | Dr. LU Hanna |
| 2023.636 | A pilot randomized controlled trial of MRI-guided focused low-intensity transcranial ultrasound stimulation (TUS) for sleep disturbances in patients with chronic tinnitus | Dr. LU Hanna |
| 2023.074 | A pilot randomized controlled trial of MRI-informed high-frequency transcranial random noise stimulation (hf-tRNS) for sleep disturbance and cognitive dysfunction in mild vascular cognitive impairment | Dr. LU Hanna |
| 2023.496 | Hong Kong Cohort of Abnormal Sleep in Ageing Population (HK-ASAP): an observational study on sleep quality, brain reserve and cognitive phenotypes in community-dwelling older adults | Dr. LU Hanna |
| 2020.488 | Decoding the cognitive trajectory of Hong Kong SuperAgers: a six-year follow-up study | Dr. LU Hanna |
| 2020.631 | Gamma-band high-definition transcranial alternating current stimulation (HD-tACS) for sleep disturbances in mild neurocognitive disorders due to Alzheimer’s disease | Dr. LU Hanna |
| 2012.094 | Characterization of MicroRNA-mediated neuronal differentiation of Mesenchymal Stem Cells for Axonal Regeneration | Prof. Lu Gang |
| 2013.216 | Characterization of MicroRNA-mediated neuronal differentiation of Mesenchymal Stem Cells for Axonal Regeneration | Prof. Lu Gang |
| 2013.169 | Study of genetic variations in predictive biomarkers of Parkinson | Prof. Lu Gang |
| 2011.116 | A primate-specific miR-637 induces mesenchymal stem cell neural differentiation through RES corepressors | Prof. Lu Gang |
| 2014.430 | A prospective cohort study on the effectiveness of psychological preparation conducted by Hospital Play Specialist in reducing need of sedation and level of anxiety in paediatric patients who undergo MRI | Ms LOY Tammy Sze wah |
| 2012.155 | Effects of an interactive eLearning Information Package (eLIP) for hospitalized older people and families to make decisions about discharge locations: A non-equivalent control group pretest and postetest design | Ms LOW Lisa P.L. |
| 2010.151 | A novel approach for the non-invasive prenatal diagnosis of sex-linked disorders | Ms LOW Lisa P. L. |
| 2014.580 | Randomized Controlled Trial on the Effectiveness of Ayres Sensory Integration Approach using by Occupational Therapist for School-aged Children with Sensory Processing Deficits | Ms. LOUIE Frances Tsui Man |
| 2024.576 | A Non-interventional Biomarker Study on the Molecular Evaluation of Archival Tumor Tissue in Subjects with Advanced or Metastatic Malignancies | Dr. LOONG Ho Fung Herbert |
| 2024.347 | Cross-cultural adaptation and validation of the Oxford dyspnoea word cue set for stimulation of emotional processing in lung cancer patients | Dr. LOONG Ho Fung Herbert |
| 2024.397 | Beamion LUNG-2: A Phase III, open-label, randomized, active-controlled, multi-centre trial evaluating orally administered zongertinib (BI 1810631) compared with standard of care as first-line treatment in patients with unresectable, locally advanced or metastatic non-squamous non-small cell lung cancer harbouring HER2 tyrosine kinase domain mutations | Dr. LOONG Ho Fung Herbert |
| 2019.477 | A Multicenter, Open-label, Single-arm, Phase Ib Dose Escalation and Multi-cohort Expansion Clinical Study to Assess the Safety and Antitumor Activity of Niraparib in Combination with MGD013 in Patients with Advanced or Metastatic Solid Tumor Who Failed Prior Treatment | Dr. LOONG Herbert Ho-fung |
| 2020.567 | A Multicenter, Open-label, Randomized Phase 2 Study to Compare the Efficacy and Safety of Lenvatinib in Combination with Ifosfamide and Etoposide versus Ifosfamide and Etoposide in Children, Adolescents and Young Adults with Relapsed or Refractory Osteosarcoma (OLIE) |
Dr. LOONG Herbert Ho Fung 龍浩鋒醫生 |
| 2019.022 | A Phase 2 Precision Oncology Study of Biomarker-Directed, Pembrolizumab- (MK-3475, SCH 900475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (KEYNOTE-495; KeyImPaCT) |
Dr. LOONG Herbert Ho Fung 龍浩鋒醫生 |
| 2019.652 | A phase Ib/II, multicenter open-label study of CS1001 in combination with regorafenib in patients with advanced or refractory solid tumors | Dr. LOONG Herbert Ho Fung |
| 2018.346 | Co-morbidities, healthcare utilization and survival outcomes of patients with soft-tissue and bone sarcomas in Hong Kong |
Dr. LOONG Herbert Ho Fung 龍浩鋒 |
| 2020.565 | A Phase 1 Study of LY3410738 Administered to Patients with Advanced Solid Tumors with IDH1 or IDH2 Mutations |
Dr. LOONG Herbert Ho Fung 龍浩鋒醫生 |
| 2019.554 | A Phase 1, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 510 in Subjects of Chinese Descent With Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation (CodeBreaK 105) |
Dr. LOONG Herbert Ho Fung 龍浩鋒醫生 |
Page 103 of 262.